Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.30
-5.1%
$1.84
$0.90
$6.80
$65.01M-0.821.76 million shs119,507 shs
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
$5.05
-0.8%
$5.17
$4.75
$9.43
$41.14M0.6612,349 shs7,763 shs
CORBF
Global Cord Blood
$1.50
+27.1%
$1.01
$0.25
$2.00
$182.33M-0.66125,075 shs9,896 shs
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$2.03
+8.6%
$2.26
$1.37
$9.13
$70.45M0.72152,941 shs249,637 shs
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Agape ATP Corporation stock logo
ATPC
Agape ATP
-5.11%-10.34%-36.89%+26.21%-70.45%
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
-0.79%+1.00%+4.55%-21.46%-3.99%
CORBF
Global Cord Blood
+27.12%+25.00%+50.00%+87.50%+25.00%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
+8.56%+10.33%+16.00%-48.35%-68.67%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.3232 of 5 stars
0.05.00.00.00.60.00.0
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
2.6973 of 5 stars
3.53.01.70.00.01.70.0
CORBF
Global Cord Blood
N/AN/AN/AN/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.4708 of 5 stars
0.02.00.00.01.82.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.00
N/AN/AN/A
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
3.00
Buy$8.5068.32% Upside
CORBF
Global Cord Blood
0.00
N/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Agape ATP Corporation stock logo
ATPC
Agape ATP
$1.29M50.27N/AN/A$0.48 per share2.71
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
$31.99M1.28$0.18 per share28.40($1.64) per share-3.08
CORBF
Global Cord Blood
$196.12M0.93$1.07 per share1.40N/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
$115K665.01N/AN/A$1.40 per share1.45
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Agape ATP Corporation stock logo
ATPC
Agape ATP
-$2.47M-$0.60N/AN/A-191.34%-30.95%-27.00%8/12/2025 (Estimated)
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
$400K-$1.06505.51N/A0.40%-1.07%0.20%N/A
CORBF
Global Cord Blood
$79.04MN/A0.00N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$32.90M-$0.94N/AN/AN/A-28,685.22%-51.35%-37.21%8/6/2025 (Estimated)

Latest CCEL, SERA, ATPC, and CORBF Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.07N/A-$0.07N/AN/A
5/14/2025Q1 2025
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
-$0.24-$0.20+$0.04-$0.20$0.06 million$0.04 million
3/31/2025Q4 2024
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A-$0.20N/A-$0.20N/A$0.36 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/AN/AN/AN/AN/A
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
$0.6011.88%N/AN/A N/A
CORBF
Global Cord Blood
N/AN/AN/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/AN/AN/AN/AN/A

Latest CCEL, SERA, ATPC, and CORBF Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/8/2025
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
quarterly$0.1511.79%5/21/20255/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Agape ATP Corporation stock logo
ATPC
Agape ATP
N/A
24.68
24.64
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
N/A
0.58
0.54
CORBF
Global Cord Blood
N/AN/AN/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
N/A
2.02
2.02

Institutional Ownership

CompanyInstitutional Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
0.01%
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
10.44%
CORBF
Global Cord Blood
N/A
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
54.64%

Insider Ownership

CompanyInsider Ownership
Agape ATP Corporation stock logo
ATPC
Agape ATP
9.67%
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
36.86%
CORBF
Global Cord Blood
0.50%
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
15.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Agape ATP Corporation stock logo
ATPC
Agape ATP
4050.01 million45.17 millionNot Optionable
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
908.08 million5.10 millionNot Optionable
CORBF
Global Cord Blood
1,200121.55 millionN/ANot Optionable
Sera Prognostics, Inc. stock logo
SERA
Sera Prognostics
12037.67 million31.72 millionOptionable

Recent News About These Companies

Sera Prognostics (NASDAQ:SERA) Raised to "Hold" at Wall Street Zen

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Agape ATP stock logo

Agape ATP NASDAQ:ATPC

$1.30 -0.07 (-5.11%)
Closing price 06/24/2025 04:00 PM Eastern
Extended Trading
$1.31 +0.01 (+1.08%)
As of 06/24/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Agape ATP Corporation, an investment holding company, supplies health and wellness products and health solution advisory services in Malaysia. It offers four series of programs that consist of various services and products under the ATP Zeta Health Program, ÉNERGÉTIQUE, BEAUNIQUE, and E.A.T.S. names. The company's products include ATP1s Survivor Select that contains various essential nutrients required by the human body to maintain normal metabolism; ATP3 Ionized Cal-Mag, a calcium and magnesium minerals supplement; ATP4 Omega Blend, an oil blend that provides a bio-effective balance of essential fatty acids, omega 3, and omega 6; ATP5 BetaMaxx, a natural immune enhancer; AGN-Vege Fruit Fiber, a nutrition-based formulation for intestines and stomach; AGP1-Iron to improve iron deficiency anemia; and YFA-Young Formula, an anti-aging and youthful maintenance supplement. It also provides BEAUNIQUE brand products comprising Mito+, an antioxidant drink for cellular, immune, metabolic, brain, and skin health; and Trim+, which inhibits the activities of carbohydrates digestive enzymes that result in a reduction of the breakdown and absorption of sugars. In addition, the company offers energy masks, including N°1 Med-Hydration, N°2 Med-Whitening, and N°3 Med-Firming, as well as hyaluronic acid serum and mousse facial cleanser under ÉNERGÉTIQUE brand; and soy protein isolate powder, and an antioxidant under Livo5 brand name. Further, it sells health and wellness products; and promotes wellness and wellbeing lifestyle through online editorials, programs, events, and campaigns, as well as provides health therapies. The company was incorporated in 2016 and is headquartered in Kuala Lumpur, Malaysia.

Cryo-Cell International stock logo

Cryo-Cell International NYSEAMERICAN:CCEL

$5.05 -0.04 (-0.79%)
Closing price 06/24/2025 04:10 PM Eastern
Extended Trading
$5.08 +0.04 (+0.69%)
As of 07:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Global Cord Blood NYSE:CORBF

$1.50 +0.32 (+27.12%)
As of 06/24/2025 01:33 PM Eastern

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Sera Prognostics stock logo

Sera Prognostics NASDAQ:SERA

$2.03 +0.16 (+8.56%)
Closing price 06/24/2025 04:00 PM Eastern
Extended Trading
$2.04 +0.01 (+0.49%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes in the United States. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in singleton pregnancies. It is also developing a portfolio of product candidates for various pregnancy-related conditions, including preterm birth, preeclampsia, molecular time-to-birth, predictive analytics, gestational diabetes mellitus, fetal growth restriction, stillbirth, and postpartum depression. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah.